雾化吸入痰热清、喜炎平对大鼠肺部的刺激性研究

谭宁; 李鹏跃; 董博宇; 赵梦迪; 杨柳; 陆洋

doi:10.3969/j.issn.1006-0111.2016.04.016

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

雾化吸入痰热清、喜炎平对大鼠肺部的刺激性研究

谭宁, 李鹏跃, 董博宇, 赵梦迪, 杨柳, 陆洋

文章导航 > 药学实践与服务 > 2016 > 34(4): 348-350,356

谭宁, 李鹏跃, 董博宇, 赵梦迪, 杨柳, 陆洋. 雾化吸入痰热清、喜炎平对大鼠肺部的刺激性研究[J]. 药学实践与服务, 2016, 34(4): 348-350,356. doi: 10.3969/j.issn.1006-0111.2016.04.016

引用本文:

TAN Ning, LI Pengyue, DONG Boyu, ZHAO Mengdi, YANG Liu, LU Yang. Study on the rat pulmonary irritation of aerosol inhaled Tanreqing and Reduning[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 348-350,356. doi: 10.3969/j.issn.1006-0111.2016.04.016

Citation:

TAN Ning, LI Pengyue, DONG Boyu, ZHAO Mengdi, YANG Liu, LU Yang. Study on the rat pulmonary irritation of aerosol inhaled Tanreqing and Reduning[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 348-350,356. doi: 10.3969/j.issn.1006-0111.2016.04.016

雾化吸入痰热清、喜炎平对大鼠肺部的刺激性研究

doi: 10.3969/j.issn.1006-0111.2016.04.016

北京中医药大学中药学院, 北京 100029

基金项目: 国家自然科学基金项目（81473363）；北京市科技新星计划（xx2015A048）

Study on the rat pulmonary irritation of aerosol inhaled Tanreqing and Reduning

School of Chinese material medica, Beijing University of Chinese Medicine, Beijing 100029, China

摘要: 目的研究中药复方痰热清和单成分喜炎平注射液的雾化吸入对大鼠肺部的刺激性。方法每种药物分为高、低浓度2个实验组，对照组灌以生理盐水。雾化吸入药物给药7 d后处死大鼠。采用大鼠支气管肺泡灌洗术，测定灌洗液中总蛋白含量和LDH酶活性，以判断两种药物对大鼠肺部的损伤程度。结果痰热清低、高浓度组肺泡灌洗液中蛋白质浓度分别为：（193.78±27.74）、（235.33±50.41） μg/ml；喜炎平两组蛋白质浓度为：（174.02±17.82）、（227.27±66.03） μg/ml；LDH酶活力单位依次为：1065.21±181.76、1467.33±101.87；307.97±47.56、1377.29±566.48。经t检验，与对照组相比，痰热清和喜炎平（低浓度和高浓度）对肺泡灌洗液中总蛋白含量无显著影响，但均能增加LDH酶的活力（P<0.05），且与浓度呈正相关；低浓度痰热清组的LDH酶活力显著高于低浓度喜炎平组（P<0.05）。结论雾化吸入痰热清、喜炎平对大鼠呼吸系统有一定的刺激性，故不宜采用雾化吸入的给药方式。
- 肺部给药 /
- 痰热清 /
- 喜炎平 /
- 支气管肺泡灌洗术 /
- 刺激性
Abstract: Objective To study the rat pulmonary irritant of aerosol inhaled Tanreqing and Reduning injection. Methods Rats were devided into two groups for each medicine (low concentration group and high concentration group), nebulized drug administration for seven days, with the control group irrigated with saline, and were sacrificed. Through bronchoalveolar lavage, excurrent bronchoalveolar lavage fluid (BALF) was used for total protein determination and LDH vitality test to evaluate pulmonary toxicity of two medicines. Results The protein concentrations of two groups in low and high concentrations of Tanreqing and Reduning respectively are (193.78±27.74),(235.33±50.41) μg/ml;(174.02±17.82),(227.27±66.03) μg/ml;LDH vitalities respectively are 1065.21±181.76,1467.33±101.87;307.97±47.56,1377.29±566.48. By t-test, compared with normal saline, there was no significant effect among these five groups on protein concentration, but these two medicine were able to improve LDH activity (P<0.05) which was more obvious in high concentration group. When two medicines were in low concentration, LDH activity was higher in Tanreqing group with statistical significance (P<0.05). Conclusion Aerosol inhaled Tanreqing and Reduning injection in rats have some pulmonary irritation and potential safety hazard in this delivery way.
- pulmonary delivery /
- Tanreqing /
- Reduning /
- excurrent bronchoalveolar lavage /
- irritation

[1]	凌祥,沈雁,孙春萌,等.肺部给药研究近况[J].药学研究,2014,33(12):711-714.
[2]	王淳,刘晓彬,权丽辉,等.中药肺部给药系统应用进展[J].世界科学技术:中医药现代化,2007,9(1):59-64.
[3]	雷卫平,吴英梅,林翠芬.痰热清注射液的临床应用[J].国际医药卫生导报,2005,11(14):110-113.
[4]	张妍,杨毅恒,刘芳,等.痰热清注射液雾化吸入治疗呼吸系统疾病的系统评价[J].中国医院用药评价与分析,2010,10(6):483-487.
[5]	唐韵.喜炎平注射液临床应用近况[J].世界临床药物,2014,35(3):184-188.
[6]	万珍,徐志锋,林俊明,等.喜炎平超声雾化吸入治疗成人急性上呼吸道感染疗效观察[J].新中医,2014,46(6):57-59.
[7]	张华静,郑德瑜.喜炎平注射液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎观察[J].中医药临床杂志,2014,26(12):1247-1248.
[8]	王晶,任吉祥,谢雁鸣,等.喜炎平注射液治疗手足口病的系统评价[J].中国中药杂志,2013,38(18):3215-3222.
[9]	耿红,吴明杰.喜炎平雾化吸入后拍背吸痰佐治小儿毛细支气管炎的临床观察[J].临床合理用药杂志,2012,5(6B):70

[1]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
[2]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[3]	戴菲菲, 傅翔, 陈琼年, 俞苏纯. 上海某二级医院革兰阴性菌流行特征的回顾性分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202305005
[4]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[5]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[6]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[7]	王耀振, 徐灿, 吕顺莉, 田泾, 张东炜. 钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 278-284. doi: 10.12206/j.issn.2097-2024.202306040
[8]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[9]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[10]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[11]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 1-8. doi: 10.12206/j.issn.2097-2024.202401073
[12]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006
[13]	陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠. UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
[14]	尹小娟, 台力丽, 肖俊峰, 季波. 铜绿假单胞菌合并按蚊伊丽莎白菌肺部感染的病例分析 . 药学实践与服务, 2024, 42(5): 223-226. doi: 10.12206/j.issn.2097-2024.202310042
[15]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[16]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035

点击查看大图

计量

文章访问数: 2852
HTML全文浏览量: 314
PDF下载量: 598
被引次数: 0

雾化吸入痰热清、喜炎平对大鼠肺部的刺激性研究

doi: 10.3969/j.issn.1006-0111.2016.04.016

北京中医药大学中药学院, 北京 100029

基金项目: 国家自然科学基金项目（81473363）；北京市科技新星计划（xx2015A048）

收稿日期: 2015-08-22
修回日期: 2016-01-03

关键词:

肺部给药 /

痰热清 /

喜炎平 /

支气管肺泡灌洗术 /

刺激性

摘要: 目的研究中药复方痰热清和单成分喜炎平注射液的雾化吸入对大鼠肺部的刺激性。方法每种药物分为高、低浓度2个实验组，对照组灌以生理盐水。雾化吸入药物给药7 d后处死大鼠。采用大鼠支气管肺泡灌洗术，测定灌洗液中总蛋白含量和LDH酶活性，以判断两种药物对大鼠肺部的损伤程度。结果痰热清低、高浓度组肺泡灌洗液中蛋白质浓度分别为：（193.78±27.74）、（235.33±50.41） μg/ml；喜炎平两组蛋白质浓度为：（174.02±17.82）、（227.27±66.03） μg/ml；LDH酶活力单位依次为：1065.21±181.76、1467.33±101.87；307.97±47.56、1377.29±566.48。经t检验，与对照组相比，痰热清和喜炎平（低浓度和高浓度）对肺泡灌洗液中总蛋白含量无显著影响，但均能增加LDH酶的活力（P<0.05），且与浓度呈正相关；低浓度痰热清组的LDH酶活力显著高于低浓度喜炎平组（P<0.05）。结论雾化吸入痰热清、喜炎平对大鼠呼吸系统有一定的刺激性，故不宜采用雾化吸入的给药方式。

English Abstract

Study on the rat pulmonary irritation of aerosol inhaled Tanreqing and Reduning

School of Chinese material medica, Beijing University of Chinese Medicine, Beijing 100029, China

Received Date: 2015-08-22
Rev Recd Date: 2016-01-03

Keywords:

Abstract: Objective To study the rat pulmonary irritant of aerosol inhaled Tanreqing and Reduning injection. Methods Rats were devided into two groups for each medicine (low concentration group and high concentration group), nebulized drug administration for seven days, with the control group irrigated with saline, and were sacrificed. Through bronchoalveolar lavage, excurrent bronchoalveolar lavage fluid (BALF) was used for total protein determination and LDH vitality test to evaluate pulmonary toxicity of two medicines. Results The protein concentrations of two groups in low and high concentrations of Tanreqing and Reduning respectively are (193.78±27.74),(235.33±50.41) μg/ml;(174.02±17.82),(227.27±66.03) μg/ml;LDH vitalities respectively are 1065.21±181.76,1467.33±101.87;307.97±47.56,1377.29±566.48. By t-test, compared with normal saline, there was no significant effect among these five groups on protein concentration, but these two medicine were able to improve LDH activity (P<0.05) which was more obvious in high concentration group. When two medicines were in low concentration, LDH activity was higher in Tanreqing group with statistical significance (P<0.05). Conclusion Aerosol inhaled Tanreqing and Reduning injection in rats have some pulmonary irritation and potential safety hazard in this delivery way.